chr2-181537025-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000885.6(ITGA4):​c.*1498G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.38 in 444,670 control chromosomes in the GnomAD database, including 35,181 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 8696 hom., cov: 33)
Exomes 𝑓: 0.41 ( 26485 hom. )

Consequence

ITGA4
NM_000885.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.567

Publications

12 publications found
Variant links:
Genes affected
ITGA4 (HGNC:6140): (integrin subunit alpha 4) The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 4 subunit. This subunit associates with a beta 1 or beta 7 subunit to form an integrin that may play a role in cell motility and migration. This integrin is a therapeutic target for the treatment of multiple sclerosis, Crohn's disease and inflammatory bowel disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
CERKL (HGNC:21699): (ceramide kinase like) This gene was initially identified as a locus (RP26) associated with an autosomal recessive form of retinitis pigmentosa (arRP) disease. This gene encodes a protein with ceramide kinase-like domains, however, the protein does not phosphorylate ceramide and its target substrate is currently unknown. This protein may be a negative regulator of apoptosis in photoreceptor cells. Mutations in this gene cause a form of retinitis pigmentosa characterized by autosomal recessive cone and rod dystrophy (arCRD). Alternative splicing of this gene results in multiple transcript variants encoding different isoforms and non-coding transcripts.[provided by RefSeq, May 2010]
CERKL Gene-Disease associations (from GenCC):
  • CERKL-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 26
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-181537025-G-A is Benign according to our data. Variant chr2-181537025-G-A is described in ClinVar as [Benign]. Clinvar id is 332981.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.613 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA4NM_000885.6 linkc.*1498G>A 3_prime_UTR_variant Exon 28 of 28 ENST00000397033.7 NP_000876.3 P13612-1
CERKLNM_201548.5 linkc.*1159C>T 3_prime_UTR_variant Exon 13 of 13 ENST00000410087.8 NP_963842.1 Q49MI3-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA4ENST00000397033.7 linkc.*1498G>A 3_prime_UTR_variant Exon 28 of 28 1 NM_000885.6 ENSP00000380227.2 P13612-1
CERKLENST00000410087.8 linkc.*1159C>T 3_prime_UTR_variant Exon 13 of 13 1 NM_201548.5 ENSP00000386725.3 Q49MI3-2
CERKLENST00000684145.1 linkc.*1159C>T 3_prime_UTR_variant Exon 12 of 12 ENSP00000508396.1 G0XYE7

Frequencies

GnomAD3 genomes
AF:
0.327
AC:
49668
AN:
151888
Hom.:
8697
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.227
Gnomad AMI
AF:
0.248
Gnomad AMR
AF:
0.344
Gnomad ASJ
AF:
0.416
Gnomad EAS
AF:
0.488
Gnomad SAS
AF:
0.632
Gnomad FIN
AF:
0.292
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.350
Gnomad OTH
AF:
0.359
GnomAD2 exomes
AF:
0.409
AC:
49715
AN:
121576
AF XY:
0.424
show subpopulations
Gnomad AFR exome
AF:
0.231
Gnomad AMR exome
AF:
0.356
Gnomad ASJ exome
AF:
0.411
Gnomad EAS exome
AF:
0.486
Gnomad FIN exome
AF:
0.277
Gnomad NFE exome
AF:
0.358
Gnomad OTH exome
AF:
0.389
GnomAD4 exome
AF:
0.408
AC:
119269
AN:
292664
Hom.:
26485
Cov.:
0
AF XY:
0.431
AC XY:
71752
AN XY:
166460
show subpopulations
African (AFR)
AF:
0.227
AC:
1858
AN:
8190
American (AMR)
AF:
0.354
AC:
9305
AN:
26260
Ashkenazi Jewish (ASJ)
AF:
0.419
AC:
4289
AN:
10238
East Asian (EAS)
AF:
0.483
AC:
4404
AN:
9118
South Asian (SAS)
AF:
0.623
AC:
36186
AN:
58126
European-Finnish (FIN)
AF:
0.270
AC:
3236
AN:
11966
Middle Eastern (MID)
AF:
0.462
AC:
504
AN:
1090
European-Non Finnish (NFE)
AF:
0.353
AC:
54427
AN:
154054
Other (OTH)
AF:
0.371
AC:
5060
AN:
13622
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3688
7376
11064
14752
18440
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.327
AC:
49689
AN:
152006
Hom.:
8696
Cov.:
33
AF XY:
0.331
AC XY:
24622
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.227
AC:
9433
AN:
41490
American (AMR)
AF:
0.345
AC:
5254
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.416
AC:
1444
AN:
3470
East Asian (EAS)
AF:
0.489
AC:
2529
AN:
5172
South Asian (SAS)
AF:
0.632
AC:
3047
AN:
4822
European-Finnish (FIN)
AF:
0.292
AC:
3087
AN:
10568
Middle Eastern (MID)
AF:
0.412
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
0.350
AC:
23799
AN:
67932
Other (OTH)
AF:
0.356
AC:
749
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1695
3389
5084
6778
8473
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
516
1032
1548
2064
2580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.339
Hom.:
19807
Bravo
AF:
0.320
Asia WGS
AF:
0.516
AC:
1795
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
3.8
DANN
Benign
0.66
PhyloP100
0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1047307; hg19: chr2-182401752; API